15 minutes to result with consumer grade SARS-CoV-2 molecular self-test at home
midge medical GmbH, Berlin, Berlin, Germany
Diagnostic technologies for identification of SARS-CoV-2 from human nasal, buccal, or saliva samples
Tech Brief: midge medical delivers a 15 minute, consumer grade molecular home-use RNA test for safely detecting SARS-CoV-2 from asymptomatic and symptomatic individuals with reliable positive and negative results available immediately. Highly scalable multi-use test device + disposable test cartridge. Includes test control and digital data transfer by smartphone app.
Small to Medium Enterprise
FIGURES OF MERIT Value Proposition: Short term (2021), test capacity will be available for massive repeated testing, carried out by laymen, no need for support person, in the comfort of your home. Scaling depends only on the invested capital; the high-volume manufacturing processes are readily transferrable to existing supply chains and manufacturing partners. We envision a licensing strategy to drive growth. In the mid-term the test will allow to identify enough people with a SARS-CoV-2 infection to “dry out” the Corona epidemic. In combination with vaccines home testing is the only reliable way of eradicating the virus for ending the pandemic. Commercial partners opportunity - High-volume manufacturing of device and/or disposable - Distribution to healthcare system - Distribution in B2C setting (i.e. pharmacies, drug stores, …) - Health professionals Investors opportunity - Extremely high-growth market opportunity with a long-term vision - Disrupt the medical diagnostics market, participate in the next generation consumer grade nucleic acid testing technology for the growing home diagnostics market - Support conquering the Corona pandemic with an approach that will generate lasting results In the long term our test accelerates the reshaping of the diagnostics market making it more patient centric.